Selection of Protein Phosphatase 2A Regulatory Subunits Is Mediated by the C Terminus of the Catalytic Subunit
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Protein phosphatase 2A (PP2A) is a family of multifunctional serine/threonine phosphatases all composed of a catalytic C, a structural A, and a regulatory B subunit. Assembly of the complex with the appropriate B subunit forms the key to the functional specificity and regulation of PP2A. Emerging evidence suggests a crucial role for methylation and phosphorylation of the PP2A C subunit in this process. In this study, we show that PP2A C subunit methylation was not absolutely required for binding the PR61/B' and PR72/B'' subunit families, whereas binding of the PR55/B subunit family was determined by methylation and the nature of the C-terminal amino acid side chain. Moreover mutation of the phosphorylatable Tyr(307) or Thr(304) residues differentially affected binding of distinct B subunit family members. Down-regulation of the PP2A methyltransferase LCMT1 by RNA interference gradually reduced the cellular amount of methylated C subunit and induced a dynamic redistribution of the remaining methylated PP2A(C) between different PP2A trimers consistent with their methylation requirements. Persistent knockdown of LCMT1 eventually resulted in specific degradation of the PR55/B subunit and apoptotic cell death. Together these results establish a crucial foundation for understanding PP2A regulatory subunit selection.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, the capacity for B subunits to bind the core AC dimer, and thus direct substrate specificity, is dictated by the accessibility and PTMs of the carboxyl-terminus of the C subunit (C-tail) (Ikehara et al., 2007; Longin et al., 2007).”
From Selective PP2A enhancement through biased heterotrimer stabilization (2020) · cites this paper as Longin et al., 2007
In the citing paper
“It has been also shown that modifications to the C-terminus can impact the catalytic activity of the enzyme, as phosphorylation of T304 and Y307 have been shown to inhibit phosphatase activity (Chen et al., 1992; Longin et al., 2007).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Longin et al., 2007
In the citing paper
“Methylation of L309 has been shown to increase the binding affinity of the PP2A core enzyme for certain regulatory subunits (such as B55α in cells) (Longin et al., 2007; Yu et al., 2001), but not every subunit family (Ikehara et al., 2007; Ogris et al., 1997; Tolstykh et al., 2000; Wei et al., 2001; Xing et al., 2006; Xu et al., 2008; Xu et al., 2006).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Longin et al., 2007
In the citing paper
“It is known that methylation of L309 is essential for binding of B family subunits to the core dimer in cells, but not members of the other three regulatory subunit families (Longin et al., 2007; Yu et al., 2001).”
From PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer (2019) · cites this paper as Longin et al., 2007
Citations
Cites
Janssens, V., & Goris, J. (2001) · Biochemical Journal · doi:10.1042/0264-6021:3530417 · Cited by 1,902
Self-citationRegulation of protein serine-threonine phosphatase type-2A by tyrosine phosphorylation
Chen, J., Martin, B. L., & Brautigan, D. L. (1992) · Science · doi:10.1126/science.1325671 · Cited by 601
Crystal structure of a protein phosphatase 2A heterotrimeric holoenzyme
Cho, U. S., & Xu, W. (2007) · Nature · doi:10.1038/nature05351 · Cited by 459
Structure of the Protein Phosphatase 2A Holoenzyme
Xu, Y., Xing, Y., Chen, Y., Chao, Y., Lin, Z., Fan, E., Yu, J. W., Strack, S., Jeffrey, P. D., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.11.033 · Cited by 450
PP2A: the expected tumor suppressor
Janssens, V., Goris, J., & Van Hoof, C. (2005) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2004.12.004 · Cited by 426
Self-citationStructure of protein phosphatase 2A core enzyme bound to tumor-inducing toxins
Xing, Y., Xu, Y., Chen, Y., Jeffrey, P. D., Chao, Y., Lin, Z., Li, Z., Strack, S., Stock, J. B., & Shi, Y. (2006) · Cell · doi:10.1016/j.cell.2006.09.025 · Cited by 334
Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits
Silverstein, A. M., Barrow, C. A., Davis, A. J., & Mumby, M. C. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.072071699 · Cited by 276
Downregulation of PP2ACdc55 Phosphatase by Separase Initiates Mitotic Exit in Budding Yeast
Queralt, E., Lehane, C., Novak, B., & Uhlmann, F. (2006) · Cell · doi:10.1016/j.cell.2006.03.038 · Cited by 240
Tolstykh, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5682 · Cited by 237
Sontag, E., Luangpirom, A., Hladik, C., Mudrak, I., Ogris, E., Speciale, S., & White, C. L. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.287 · Cited by 228
Research works printed but not linked: 2
- Janssens, 2001, Biochem. J., 353, 417, 10.1042/bj3530417 · DOI · Paper page
- Bryant, 1999, Biochem. J., 339, 241, 10.1042/bj3390241 · doi:10.1042/bj3390241 · Paper page
Cited by
Serine/threonine phosphatases: mechanism through structure
Shi, Y. (2009) · Cell · doi:10.1016/j.cell.2009.10.006 · Cited by 1,488
“Compelling evidence demonstrated that methylation plays an important, perhaps indispensable, role for the assembly of PP2A holoenzymes in cells (Bryant et al., 1999; Gentry et al., 2005; Kloeker et al., 1997; Longin et al., 2007a; Tolstykh et al., 2000; Wei et al., 2001; Wu et al., 2000; Yu et al., 2001).”
BackgroundInfluentialPhosphatase‐mediated crosstalk between MAPK signaling pathways in the regulation of cell survival
Junttila, M. R., Li, S., & Westermarck, J. (2008) · The FASEB Journal · doi:10.1096/fj.06-7859rev · Cited by 826
Tau and neurodegenerative disease: the story so far
Iqbal, K., Liu, F., & Gong, C.-X. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.225 · Cited by 806
Phosphatase: PP2A structural importance, regulation and its aberrant expression in cancer
Seshacharyulu, P., Pandey, P., Datta, K., & Batra, S. K. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.02.036 · Cited by 481
PP2A holoenzyme assembly: In cauda venenum (the sting is in the tail)
Janssens, V., Longin, S., & Goris, J. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.004 · Cited by 390
Self-citationPP2A as a master regulator of the cell cycle
Wlodarchak, N., & Xing, Y. (2016) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2016.1143913 · Cited by 371
All roads lead to PP 2A: exploiting the therapeutic potential of this phosphatase
Sangodkar, J., Farrington, C. C., McClinch, K., Galsky, M. D., Kastrinsky, D. B., & Narla, G. (2016) · The FEBS Journal · doi:10.1111/febs.13573 · Cited by 312
Schmitz, M. H. A., Held, M., Janssens, V., Hutchins, J. R. A., Hudecz, O., Ivanova, E., Goris, J., Trinkle-Mulcahy, L., Lamond, A. I., Poser, I., et al. (2010) · Nature Cell Biology · doi:10.1038/ncb2092 · Cited by 316
Self-citationStructure of a Protein Phosphatase 2A Holoenzyme: Insights into B55-Mediated Tau Dephosphorylation
Xu, Y., Chen, Y., Zhang, P., Jeffrey, P. D., & Shi, Y. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.08.006 · Cited by 284
Tau protein phosphatases in Alzheimer's disease: The leading role of PP2A
Martin, L., Latypova, X., Wilson, C. M., Magnaudeix, A., Perrin, M.-L., & Terro, F. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2012.06.008 · Cited by 250
Qin, K., Yu, M., Fan, J., Wang, H., Zhao, P., Zhao, G., Zeng, W., Chen, C., Wang, Y., Wang, A., et al. (2024) · Genes & Diseases · doi:10.1016/j.gendis.2023.01.030 · Cited by 217
Structural mechanism of demethylation and inactivation of protein phosphatase 2A
Xing, Y., Li, Z., Chen, Y., Stock, J. B., Jeffrey, P. D., & Shi, Y. (2008) · Cell · doi:10.1016/j.cell.2008.02.041 · Cited by 206
Sents, W., Ivanova, E., Lambrecht, C., Haesen, D., & Janssens, V. (2013) · The FEBS Journal · doi:10.1111/j.1742-4658.2012.08579.x · Cited by 204
Self-citationO’Connor, C. M., Perl, A., Leonard, D., Sangodkar, J., & Narla, G. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.10.008 · Cited by 190
Selective PP2A enhancement through biased heterotrimer stabilization
Leonard, D., Huang, W., Izadmehr, S., O’Connor, C. M., Wiredja, D. D., Wang, Z., Zaware, N., Chen, Y., Schlatzer, D. M., Kiselar, J., et al. (2020) · Cell · doi:10.1016/j.cell.2020.03.038 · Cited by 176
Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model
Lee, K.-W., Chen, W., Junn, E., Im, J.-Y., Grosso, H., Sonsalla, P. K., Feng, X., Ray, N., Fernandez, J. R., Chao, Y., et al. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6513-10.2011 · Cited by 184
Regulation and Function of Protein Kinases and Phosphatases
Cheng, H.-C., Qi, R. Z., Paudel, H., & Zhu, H.-J. (2011) · Enzyme Research · doi:10.4061/2011/794089 · Cited by 168
The structural basis for tight control of PP2A methylation and function by LCMT-1
Stanevich, V., Jiang, L., Satyshur, K. A., Li, Y., Jeffrey, P. D., Li, Z., Menden, P., Semmelhack, M. F., & Xing, Y. (2011) · Molecular Cell · doi:10.1016/j.molcel.2010.12.030 · Cited by 142
“Knockdown of LCMT-1 reduces the cellular level of PP2A methylation and induces apoptosis in mammalian cells (Lee and Pallas, 2007; Longin et al., 2007).”
BackgroundInfluentialProtein phosphatase 2A regulatory subunits and cancer
Eichhorn, P. J. A., Creyghton, M. P., & Bernards, R. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2008.05.005 · Cited by 513
Cross talk between PI3K-AKT-GSK-3β and PP2A pathways determines tau hyperphosphorylation
Wang, Y., Yang, R., Gu, J., Yin, X., Jin, N., Xie, S., Wang, Y., Chang, H., Qian, W., Shi, J., et al. (2015) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.035 · Cited by 134
Physiologic functions of PP2A: Lessons from genetically modified mice
Reynhout, S., & Janssens, V. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.07.010 · Cited by 124
Self-citationB56δ-related protein phosphatase 2A dysfunction identified in patients with intellectual disability
Houge, G., Haesen, D., Vissers, L. E. L. M., Mehta, S., Parker, M. J., Wright, M., Vogt, J., McKee, S., Tolmie, J. L., Cordeiro, N., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci79860 · Cited by 124
“The different PP2A B-subunit cDNAs were in a GST-tag eukaryotic expression vector, as described (19).”
BackgroundSelf-citationHaesen, D., Abbasi Asbagh, L., Derua, R., Hubert, A., Schrauwen, S., Hoorne, Y., Amant, F., Waelkens, E., Sablina, A., & Janssens, V. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-3342 · Cited by 124
Self-citationNon-genomic mechanisms of protein phosphatase 2A (PP2A) regulation in cancer
Kauko, O., & Westermarck, J. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.01.005 · Cited by 111
Protein Phosphatase 2A Reactivates FOXO3a through a Dynamic Interplay with 14-3-3 and AKT
Singh, A., Ye, M., Bucur, O., Zhu, S., Tanya Santos, M., Rabinovitz, I., Wei, W., Gao, D., Hahn, W. C., & Khosravi-Far, R. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e09-09-0795 · Cited by 117
Protein phosphatases in the regulation of mitosis
Nilsson, J. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201809138 · Cited by 112
Protein phosphatase 2A (PP2A), a drugable tumor suppressor in Ph1(+) leukemias
Perrotti, D., & Neviani, P. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-008-9119-x · Cited by 127
Louis, J. V., Martens, E., Borghgraef, P., Lambrecht, C., Sents, W., Longin, S., Zwaenepoel, K., Pijnenborg, R., Landrieu, I., Lippens, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018777108 · Cited by 112
“In addition, by using carefully equilibrated amounts of PP2AT55α and PP2AT61δ retrieved from COS7 cells expressing PR55/Bα and PR61/B’δ GST fusion proteins (20), PP2AT55α proved at least 15-fold better in dephosphorylating AT8 and AT180 than PP2AT61δ (Fig.”
MethodSelf-citationTau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A
Zhou, X.-W., Gustafsson, J.-Å., Tanila, H., Bjorkdahl, C., Liu, R., Winblad, B., & Pei, J.-J. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.05.013 · Cited by 101
Structural basis of PP2A activation by PTPA, an ATP-dependent activation chaperone
Guo, F., Stanevich, V., Wlodarchak, N., Sengupta, R., Jiang, L., Satyshur, K. A., & Xing, Y. (2014) · Cell Research · doi:10.1038/cr.2013.138 · Cited by 100
PP2A holoenzymes, substrate specificity driving cellular functions and deregulation in cancer
(2019) · Advances in Cancer Research · doi:10.1016/bs.acr.2019.03.009 · Cited by 93
Determinants for Substrate Specificity of Protein Phosphatase 2A
Slupe, A. M., Merrill, R. A., & Strack, S. (2011) · Enzyme Research · doi:10.4061/2011/398751 · Cited by 90
Molecular Mechanisms Underlying Cardiac Protein Phosphatase 2A Regulation in Heart
DeGrande, S. T., Little, S. C., Nixon, D. J., Wright, P., Snyder, J., Dun, W., Murphy, N., Kilic, A., Higgins, R., Binkley, P. F., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.426957 · Cited by 90
Amyloid-β and Tau in Alzheimer’s disease: pathogenesis, mechanisms, and interplay
Abdulkhaliq, A. A., Kim, B., Almoghrabi, Y. M., Khan, J., Ajoolabady, A., Ren, J., Bahijri, S., Tuomilehto, J., Borai, A., & Pratico, D. (2026) · Cell Death & Disease · doi:10.1038/s41419-025-08186-8 · Cited by 87
Nuclear Reformation at the End of Mitosis
Schellhaus, A. K., Magistris, P. D., & Antonin, W. (2015) · Journal of Molecular Biology · doi:10.1016/j.jmb.2015.09.016 · Cited by 91
Lillo, C., Kataya, A. R. A., HEIDARI, B., Creighton, M. T., Nemie-Feyissa, D., Ginbot, Z., & Jonassen, E. M. (2014) · Plant Cell & Environment · doi:10.1111/pce.12364 · Cited by 104
Sontag, J.-M., Nunbhakdi-Craig, V., Montgomery, L., Arning, E., Bottiglieri, T., & Sontag, E. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2816-08.2008 · Cited by 77
Sacharidou, A., Chambliss, K. L., Ulrich, V., Salmon, J. E., Shen, Y.-M. P., Herz, J., Hui, D. Y., Terada, L. S., Shaul, P. W., & Mineo, C. (2018) · Blood · doi:10.1182/blood-2017-11-814681 · Cited by 85
Kauko, O., Imanishi, S. Y., Kulesskiy, E., Yetukuri, L., Laajala, T. D., Sharma, M., Pavic, K., Aakula, A., Rupp, C., Jumppanen, M., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.011265 · Cited by 65
“S1I) may be at least partly due to the direct inhibition of the catalytic activity of PP2Ac by SET (27, 28) and the limited selectivity toward specific B-subunit– containing PP2A trimers, as is the case with PME-1 or CIP2A (10, 26, 39).”
BackgroundBachovchin, D. A., Zuhl, A. M., Speers, A. E., Wolfe, M. R., Weerapana, E., Brown, S. J., Rosen, H., & Cravatt, B. F. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm200502u · Cited by 71
Protein Phosphatase 2A as a Therapeutic Target in Acute Myeloid Leukemia
Arriazu, E., Pippa, R., & Odero, M. D. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00078 · Cited by 66
Restricted Protein Phosphatase 2A Targeting by Merkel Cell Polyomavirus Small T Antigen
Kwun, H. J., Shuda, M., Camacho, C. J., Gamper, A. M., Thant, M., Chang, Y., & Moore, P. S. (2015) · Journal of Virology · doi:10.1128/jvi.00157-15 · Cited by 78
Elgenaidi, I. S., & Spiers, P. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.02.011 · Cited by 73
Jackson, J. B., & Pallas, D. C. (2012) · Neoplasia · doi:10.1593/neo.12768 · Cited by 60
Reynhout, S., Jansen, S., Haesen, D., Belle, S. V., de Munnik, S. A., Bongers, E. M. H. F., Schieving, J., Marcelis, C., Amiel, J., Rio, M., et al. (2018) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2018.12.002 · Cited by 67
Self-citationCorrecting abnormalities in miR‐124/PTPN1 signaling rescues tau pathology in Alzheimer’s disease
Hou, T., Zhou, Y., Zhu, L., Wang, X., Pang, P., Wang, D., Liuyang, Z., Man, H., Lu, Y., Zhu, L., et al. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.14961 · Cited by 62
Protein Phosphatase 2A as a Potential Target for Anticancer Therapy
Kalev, P., & A. Sablina, A. (2011) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/187152011794941172 · Cited by 58
Spatial control of protein phosphatase 2A (de)methylation
Longin, S., Zwaenepoel, K., Martens, E., Louis, J. V., Rondelez, E., Goris, J., & Janssens, V. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.07.030 · Cited by 59
Self-citationHu, W., Wu, F., Zhang, Y., Gong, C.-X., Iqbal, K., & Liu, F. (2017) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2017.00311 · Cited by 58
Sontag, J., Nunbhakdi‐Craig, V., Mitterhuber, M., Ogris, E., & Sontag, E. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07049.x · Cited by 57
“In mammalian cells, methylation promotes the biogenesis and stabilization of major PP2A holoenzymes containing the Ba (or PPP2R2A) subunit (Ogris et al. 1997; Bryant et al. 1999; Tolstykh et al. 2000; Yu et al. 2001; Schild et al. 2006a; Longin et al. 2007; Nunbhakdi-Craig et al. 2007).”
BackgroundInfluentialNicholls, R. E., Sontag, J.-M., Zhang, H., Staniszewski, A., Yan, S., Kim, C. Y., Yim, M., Woodruff, C. M., Arning, E., Wasek, B., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1521018113 · Cited by 56
Hwang, J., Lee, J. A., & Pallas, D. C. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.739920 · Cited by 56
“4),consistentwithpreviousreportsofdifferentialeffectsofmethylation on different PP2A complexes (19, 24, 48).”
BackgroundRegulation of protein phosphatase 2A (PP2A) tumor suppressor function by PME-1
Kaur, A., & Westermarck, J. (2016) · Biochemical Society Transactions · doi:10.1042/bst20160161 · Cited by 55
Assembly and structure of protein phosphatase 2A
Shi, Y. (2009) · Science in China Series C Life Sciences · doi:10.1007/s11427-009-0018-3 · Cited by 69
Wei, H., Zhang, H., Wang, X., Xie, J., An, D., Wan, L., Wang, J., Zeng, Y., Shu, X., Westermarck, J. K., et al. (2020) · Neurotherapeutics · doi:10.1007/s13311-020-00841-6 · Cited by 61
Lin, H., Miller, M. L., Granas, D. M., & Dutcher, S. K. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003841 · Cited by 52
Raman, D., & Pervaiz, S. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101105 · Cited by 59
Ortega-Gutiérrez, S., Leung, D., Ficarro, S., Peters, E. C., & Cravatt, B. F. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002486 · Cited by 50
“importance of which has been recently suggested [ 38 ].”
Park, H.-J., Lee, K.-W., Oh, S. E., Yan, R., Zhang, J., Beach, T. G., Adler, C. H., Voronkov, M. V., Braithwaite, S. P., Stock, J. B., et al. (2017) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx110 · Cited by 55
Downregulation of protein phosphatase 2A by apolipoprotein E: Implications for Alzheimer's disease
Theendakara, V. P., Bredesen, D. E., & Rao, R. V. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.002 · Cited by 48
PP2A-B55: substrates and regulators in the control of cellular functions
Amin, P., Awal, S., Vigneron, S., Roque, S., Méchali, F., Labbé, J. C., Lorca, T., & Castro, A. (2021) · Oncogene · doi:10.1038/s41388-021-02068-x · Cited by 48
Switzer, C. H., Ridnour, L. A., Cheng, R. Y. S., Sparatore, A., Del Soldato, P., Moody, T. W., Vitek, M. P., Roberts, D. D., & Wink, D. A. (2009) · Oncogene · doi:10.1038/onc.2009.244 · Cited by 46
País, S. M., Besteiro, M. A. G., Téllez-Iñón, M. T., & Capiati, D. A. (2009) · Planta · doi:10.1007/s00425-009-0923-5 · Cited by 48
PP2A Inactivation Mediated by PPP2R4 Haploinsufficiency Promotes Cancer Development
Sents, W., Meeusen, B., Kalev, P., Radaelli, E., Sagaert, X., Miermans, E., Haesen, D., Lambrecht, C., Dewerchin, M., Carmeliet, P., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2911 · Cited by 42
Self-citationAltering phosphorylation in cancer through PP2A modifiers
Johnson, H., Narayan, S., & Sharma, A. K. (2024) · Cancer Cell International · doi:10.1186/s12935-023-03193-1 · Cited by 47
Kamenz, J., Gelens, L., & Ferrell, J. E. (2020) · Current Biology · doi:10.1016/j.cub.2020.11.058 · Cited by 45
Kolupaeva, V., Daempfling, L., & Basilico, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01730-12 · Cited by 37
Yao, X.-Q., Li, X.-C., Zhang, X.-X., Yin, Y.-Y., Liu, B., Luo, D.-J., Wang, Q., Wang, J.-Z., & Liu, G.-P. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.06.018 · Cited by 37
The PP2A subunit PR130 is a key regulator of cell development and oncogenic transformation
Dzulko, M., Pons, M., Henke, A., Schneider, G., & Krämer, O. H. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188453 · Cited by 47
Yu, U.-Y., Yoo, B. C., & Ahn, J. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.2.155 · Cited by 40
Kurimchak, A., & Graña, X. (2014) · Cell Cycle · doi:10.4161/15384101.2014.985069 · Cited by 39
GSK-3β is Dephosphorylated by PP2A in a Leu309 Methylation-Independent Manner
Chu, D., Tan, J., Xie, S.-T., Jin, N., Yin, X., Gong, C., Iqbal, K., & Liu, F. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150497 · Cited by 37
Wang, X., Wang, R., Luo, M., Li, C., Wang, H.-X., Huan, C., Qu, Y., Liao, Y., & Mao, X. (2017) · Oncotarget · doi:10.18632/oncotarget.16593 · Cited by 35
Braithwaite, S. P., Voronkov, M. V., Stock, J. B., & Mouradian, M. M. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.01.031 · Cited by 35
miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA
Orlandella, F. M., Mariniello, R. M., Iervolino, P. L. C., Imperlini, E., Mandola, A., Verde, A., Stefano, A. E. D., Pane, K., Franzese, M., Esposito, S., et al. (2019) · Endocrine · doi:10.1007/s12020-019-01910-3 · Cited by 32
Ricotta, D., Hansen, J., Preiss, C., Teichert, D., & Höning, S. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707166200 · Cited by 32
PPP2R5A: A multirole protein phosphatase subunit in regulating cancer development
Mao, Z., Liu, C., Lin, X., Sun, B., & Su, C. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.11.024 · Cited by 30
Zwaenepoel, K., Louis, J. V., Goris, J., & Janssens, V. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-393 · Cited by 30
“Furthermore, phosphorylation and methylation of the catalytic C subunit play an important role in the assembly of specific trimeric holoenzymes [4,5].”
BackgroundSelf-citationLajarín-Cuesta, R., Nanclares, C., Arranz-Tagarro, J.-A., González‐Lafuente, L., Arribas, R. L., de Brito, M. A., Gandía, L., & Ríos, C. D. L. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00478 · Cited by 32
Mi, Y., Gurumurthy, R. K., Zadora, P. K., Meyer, T. F., & Chumduri, C. (2018) · mBio · doi:10.1128/mbio.01465-18 · Cited by 32
Nasa, I., Cressey, L. E., Kruse, T., Hertz, E. P. T., Gui, J., Graves, L. M., Nilsson, J., & Kettenbach, A. N. (2020) · Science Signaling · doi:10.1126/scisignal.aba7823 · Cited by 30
Functional importance of PP2A regulatory subunit loss in breast cancer
Watt, L. F., Panicker, N., Mannan, A., Copeland, B., Kahl, R. G. S., Dun, M. D., Young, B., Roselli, S., & Verrills, N. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4403-5 · Cited by 29
“PP2A-Ba subunits preferentially bind to PP2A-C in its methylated state, and reduced M(309)-PP2A-C leads to reduced PP2A-Ba expression, presumably by protein degradation [29, 38].”
BackgroundProtein Phosphatase 2A as a Drug Target in the Treatment of Cancer and Alzheimer’s Disease
Wei, H., Zhang, H., Xie, J., Meng, D., Wang, X., Ke, D., Zeng, J., & Liu, R. (2020) · Current Medical Science · doi:10.1007/s11596-020-2140-1 · Cited by 30
Regulation and role of the PP2A-B56 holoenzyme family in cancer
Peris, I., Romero-Murillo, S., Vicente, C., Narla, G., & Odero, M. D. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188953 · Cited by 30
Regulation of PP2A, PP4, and PP6 holoenzyme assembly by carboxyl-terminal methylation
Lyons, S. P., Greiner, E. C., Cressey, L. E., Adamo, M. E., & Kettenbach, A. N. (2021) · Scientific Reports · doi:10.1038/s41598-021-02456-z · Cited by 27
PP2A contributes to endothelial death in high glucose: inhibition by benfotiamine
Du, Y., Kowluru, A., & Kern, T. S. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00676.2009 · Cited by 28
Berrou, E., & Bryckaert, M. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.12.002 · Cited by 26
Li, J., Han, S., Qian, Z., Su, X., Fan, S., Fu, J., Liu, Y., Yin, X., Gao, Z., Zhang, J., et al. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.27146 · Cited by 27
Yabe, R., Tsuji, S., Mochida, S., Ikehara, T., Usui, T., Ohama, T., & Sato, K. (2018) · FEBS Open Bio · doi:10.1002/2211-5463.12485 · Cited by 29
Brautigan, D. L., Farrington, C. C., & Narla, G. (2021) · Clinical Science · doi:10.1042/cs20201367 · Cited by 29
Cellular inhibitors of Protein Phosphatase PP2A in cancer.
Haesen, D., Sents, W., Ivanova, E., Lambrecht, C., & Janssens, V. (2012) · Lirias · Cited by 33
Self-citationMethylation of protein phosphatase 2A—Influence of regulators and environmental stress factors
Creighton, M. T., Kołton, A., Kataya, A. R. A., Maple‐Grødem, J., Averkina, I. O., Heidari, B., & Lillo, C. (2017) · Plant Cell & Environment · doi:10.1111/pce.13038 · Cited by 24
Challenges and Reinterpretation of Antibody-Based Research on Phosphorylation of Tyr307 on PP2Ac
Mazhar, S., Léonard, D., Sosa, A., Schlatzer, D., Thomas, D., & Narla, G. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.012 · Cited by 22
Avelar, R. A., Armstrong, A. J., Carvette, G., Gupta, R., Puleo, N., Colina, J. A., Joseph, P. L., Sobeck, A. M., O’Connor, C. M., Raines, B., et al. (2023) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-21-0880 · Cited by 28
Frohner, I. E., Mudrak, I., Schüchner, S., Anrather, D., Hartl, M., Sontag, J., Sontag, E., Wadzinski, B. E., Preglej, T., Ellmeier, W., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.035 · Cited by 25
Neale, D. B., Morris, J. C., Verrills, N. M., & Ammit, A. J. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108834 · Cited by 27
PP2A-B55 Holoenzyme Regulation and Cancer
Goguet-Rubio, P., Amin, P., Awal, S., Vigneron, S., Charrasse, S., Méchali, F., Labbé, J. C., Lorca, T., & Castro, A. (2020) · Biomolecules · doi:10.3390/biom10111586 · Cited by 25
Light regulation of nitrate reductase by catalytic subunits of protein phosphatase 2A
Creighton, M. T., Sanmartín, M., Kataya, A. R. A., Averkina, I. O., Heidari, B., Nemie-Feyissa, D., Sánchez‐Serrano, J. J., & Lillo, C. (2017) · Planta · doi:10.1007/s00425-017-2726-4 · Cited by 21
Interplay between Phosphatases and the Anaphase-Promoting Complex/Cyclosome in Mitosis
Kataria, M., & Yamano, H. (2019) · Cells · doi:10.3390/cells8080814 · Cited by 28
Effects of carboxyl-terminal methylation on holoenzyme function of the PP2A subfamily
Nasa, I., & Kettenbach, A. N. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200177 · Cited by 23
Metadata
- Authors
- Longin, S., Zwaenepoel, K., Louis, J. V., Dilworth, S., Goris, J., & Janssens, V.
- Affiliations
- KU Leuven (BE)
- Hammersmith Hospital (GB)
- Corresponding author
- Janssens, Veerle
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2007-09
- Volume
- 282
- Issue
- 37
- Pages
- 26971-26980
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1988862655
- Cited by
- 184
- References
- 42
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 4 · 2021: 14 · 2020: 17 · 2019: 9 · 2018: 11 · 2017: 14 · 2016: 8 · 2015: 7 · 2014: 7 · 2013: 9 · 2012: 12
- FWCI
- 4.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 4803 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- protein phosphatase 2A, apoptosis
- MeSH terms
- Animals, Cell Survival, Chlorocebus aethiops, HeLa Cells, Humans, Methylation, Methyltransferases, Phosphoprotein Phosphatases, Phosphorylation, Structure-Activity Relationship, Apoptosis, COS Cells, Catalytic Domain, Protein Phosphatase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.